VOYA INVESTMENT MANAGEMENT LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1068837
ATLANTA, GA
Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$235,347,566
-$19,600,335 QoQ
Shares Held
527,047
-6.3% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 84.58828150051134.ToString("F0")%
None 15.41171849948866.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,307,060,416 across 174 Biotechnology names. VRTX ranks #2 (18.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
349,912 | $270,356,007 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
527,047 | $235,347,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,488 | $49,130,223 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
454,383 | $47,891,967 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
656,129 | $41,139,286 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
538,980 | $40,024,653 | |
| 7 | INSM |
INSMED Inc
|
243,706 | $39,850,804 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
725,409 | $35,661,105 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $235,347,566 | 527,047 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $254,947,901 | 562,352 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $169,289,131 | 432,257 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $311,481,508 | 699,644 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $401,013,043 | 827,138 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $281,368,905 | 698,706 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $436,268,758 | 938,051 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $694,959,893 | 1,482,676 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $392,689,461 | 939,426 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $315,538,311 | 775,488 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $298,720,829 | 859,035 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $291,013,732 | 826,955 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $286,472,670 | 909,235 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $345,137,437 | 1,195,157 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $274,721,631 | 948,821 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $70,460,743 | 250,047 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $29,324,676 | 112,368 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $25,440,000 | 115,847 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $23,397,495 | 128,990 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $27,277,110 | 135,283 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $32,153,345 | 149,627 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $37,522,045 | 158,763 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $221,402,817 | 813,622 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $247,209,124 | 851,535 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $243,998,688 | 1,025,420 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||